3,511 results found

Manitoba has implemented a Biosimilars Initiative effective August 1, 2024. Manitoba is the last province in Canada to implement a biosimilar policy that requires patients receiving funding under the Manitoba Pharmacare...

As of October 2, 2015, manufacturers of wine and liquor may be able to sell their products at markets managed or carried on by municipalities and regional districts.

As previously reported, the 2018 Federal Budget announced the creation of an Advisory Council on the Implementation of National Pharmacare.

As of January 1, 2013, producers of pharmaceuticals, including natural heath products, are now required to provide for the collection and disposal of expired or unused pharmaceutical products in Ontario.

On January 18, 2018 the Education Law Group broadcast a Morning Recess webinar on the issue of cannabis in schools. A copy of the podcast can be requested at [email protected].

For complete details about these proceedings, click here.

These changes are summarized in CDR Update – Issue 138, and will be enforced for all submissions and resubmissions received on or after July 27, 2018.

Health Canada has published information on two new disease risk reduction/therapeutic claims permitted for use on food products

Eliminate the requirement for filing clinical case reports in a filed submission or supplement, unless requested by the Minister, in order to alleviate administrative burden.

Health Canada made an announcement today with respect to the update on the legalization and regulation of cannabis.The most pertinent information disclosed is below:

Find the new Ontario Cannabis Licence Act, 2018 and Regulations here:

New amendments to Ontario regulations have given pharmacists access to a wider catalogue of vaccines that they are able to provide.

On October 9, 2013, the Ontario Government advised that it was going to introduce legislation that requires large chain restaurants to place caloric and other nutritional information on their menus and menu boards.

The amendments to the Regulations are expected to be effective as of July 1, 2020.

We reported on the six Federal Court and three FCA PMNOC Regulations decisions publicly released in 2017.

On August 20, 2018, the Federal Court dismissed Valeant's PMNOC application regarding Ranbaxy's bupropion extended-release tablets and Patent No. 2,524,300.

Following release of a white paper in March, on December 9, 2017, Health Canada released proposed amendments to the Food and Drug Regulations under which "clinical summaries, reports...

Radio-Canada interviews Quebec City lawyer, Jean-Raphaël Champagne, about the legalization of cannabis and the municipal regulation.